# Baxter Canada invests over $26M in Alliston facility for IV and dialysis solutions

Baxter Canada announced a total investment of over $26 million in its Alliston, Ontario facility, including $7.5 million in 2018 and an additional $19 million over the next two years, to maintain regulatory compliance and prepare for FDA registration.

- Type: Investment
- Announced: 2018-12-13
- Where: Alliston, Ontario, Canada
- Value: $26.0M
- Status: announced
- Products: intravenous fluids, peritoneal dialysis solutions
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Baxter Canada](https://endata.com/companies/36138.md)

## Sources

- [baxter.ca](https://www.baxter.ca/baxter-newsroom/baxter-canada-invests-over-26-million-alliston-facility), 2018-12-13: "The Alliston facility is truly best in class, from our management system with continuous improvement at its core, to a culture of quality and safety."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.